Modelling the contribution that different sexual practices involving the oropharynx and saliva have on


Journal

Sexually transmitted infections
ISSN: 1472-3263
Titre abrégé: Sex Transm Infect
Pays: England
ID NLM: 9805554

Informations de publication

Date de publication:
05 2021
Historique:
received: 27 04 2020
revised: 28 09 2020
accepted: 03 10 2020
pubmed: 20 11 2020
medline: 15 12 2021
entrez: 19 11 2020
Statut: ppublish

Résumé

The spectrum of sexual practices that transmit To test our aim, we developed eight compartmental models. We first used a baseline model (model 1) that included no sequential sexual practices. We then added three possible sequential transmission routes to model 1: (1) oral sex followed by anal sex (or vice versa) (model 2); (2) using saliva as a lubricant for penile-anal sex (model 3) and (3) oral sex followed by oral-anal sex (rimming) or vice versa (model 4). The next four models (models 5-8) used combinations of the three transmission routes. The baseline model could only replicate infection at the single anatomical site and underestimated multisite infection. When we added the three transmission routes to the baseline model, oral sex, followed by anal sex or vice versa, could replicate the prevalence of multisite infection. The other two transmission routes alone or together could not replicate multisite infection without the inclusion of oral sex followed by anal sex or vice versa. Our gonorrhoea model suggests sexual practices that involve oral followed by anal sex (or vice versa) may be important for explaining the high proportion of multisite infection.

Sections du résumé

BACKGROUND
The spectrum of sexual practices that transmit
METHODS
To test our aim, we developed eight compartmental models. We first used a baseline model (model 1) that included no sequential sexual practices. We then added three possible sequential transmission routes to model 1: (1) oral sex followed by anal sex (or vice versa) (model 2); (2) using saliva as a lubricant for penile-anal sex (model 3) and (3) oral sex followed by oral-anal sex (rimming) or vice versa (model 4). The next four models (models 5-8) used combinations of the three transmission routes.
RESULTS
The baseline model could only replicate infection at the single anatomical site and underestimated multisite infection. When we added the three transmission routes to the baseline model, oral sex, followed by anal sex or vice versa, could replicate the prevalence of multisite infection. The other two transmission routes alone or together could not replicate multisite infection without the inclusion of oral sex followed by anal sex or vice versa.
CONCLUSIONS
Our gonorrhoea model suggests sexual practices that involve oral followed by anal sex (or vice versa) may be important for explaining the high proportion of multisite infection.

Identifiants

pubmed: 33208511
pii: sextrans-2020-054565
doi: 10.1136/sextrans-2020-054565
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

183-189

Informations de copyright

© Author(s) (or their employer(s)) 2021. No commercial re-use. See rights and permissions. Published by BMJ.

Déclaration de conflit d'intérêts

Competing interests: None declared.

Auteurs

Xianglong Xu (X)

China Australia Joint Research Center for Infectious Diseases, Xian Jiaotong University, Xi'an, Shaanxi, China.
Central Clinical School, Monash University, Clayton, Victoria, Australia.
Melbourne Sexual Health Centre, Alfred Health, Carlton, Victoria, Australia.

Eric P F Chow (EPF)

Central Clinical School, Monash University, Clayton, Victoria, Australia.
Melbourne Sexual Health Centre, Alfred Health, Carlton, Victoria, Australia.
Centre for Epidemiology and Biostatistics, University of Melbourne, Melbourne, Victoria, Australia.

Jason J Ong (JJ)

China Australia Joint Research Center for Infectious Diseases, Xian Jiaotong University, Xi'an, Shaanxi, China.
Central Clinical School, Monash University, Clayton, Victoria, Australia.
Melbourne Sexual Health Centre, Alfred Health, Carlton, Victoria, Australia.

Christian J P A Hoebe (CJPA)

Department of Infectious Diseases, South Limburg Public Health Services, Geleen, The Netherlands.
Department of Medical Microbiology, Care and Public Health Research Institute (CAPHRI), Maastricht University Medical Centre (MUMC+), Maastricht, the Netherlands.

Deborah Williamson (D)

Melbourne Diagnostic Unit Public Health Laboratory, University of Melbourne, Melbourne, Victoria, Australia.
Doherty Applied Microbial Genomics, Doherty Institute, The University of Melbourne, Melbourne, Victoria, Australia.
Microbiological Diagnostic Unit Public Health Laboratory, Department of Microbiology & Immunology, Doherty Institute, The University of Melbourne, Melbourne, Victoria, Australia.

Mingwang Shen (M)

China Australia Joint Research Center for Infectious Diseases, Xian Jiaotong University, Xi'an, Shaanxi, China.

Fabian Yuh Shiong Kong (FYS)

Centre for Epidemiology and Biostatistics, University of Melbourne, Melbourne, Victoria, Australia.

Jane S Hocking (JS)

China Australia Joint Research Center for Infectious Diseases, Xian Jiaotong University, Xi'an, Shaanxi, China.
Melbourne School of Population and Global Health, University of Melbourne, Carlton, Victoria, Australia.

Christopher K Fairley (CK)

China Australia Joint Research Center for Infectious Diseases, Xian Jiaotong University, Xi'an, Shaanxi, China.
Central Clinical School, Monash University, Clayton, Victoria, Australia.
Melbourne Sexual Health Centre, Alfred Health, Carlton, Victoria, Australia.

Lei Zhang (L)

China Australia Joint Research Center for Infectious Diseases, Xian Jiaotong University, Xi'an, Shaanxi, China lei.zhang1@monash.edu.
Central Clinical School, Monash University, Clayton, Victoria, Australia.
Melbourne Sexual Health Centre, Alfred Health, Carlton, Victoria, Australia.
Department of Epidemiology and Biostatistics, College of Public Health, Zhengzhou University, Zhengzhou, People's Republic of China.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH